Magstim Logo

NHS clinical trial could pave the way for new depression treatment

How we treat depression in the future may be set to change as the NHS begins an unprecedented two year study using transcranial magnetic stimulation (TMS).

By |2020-11-05T19:22:47+00:00November 19th, 2018|Company News, TMS Therapy|0 Comments

Magstim Group, Inc. appoints Lothar Krinke as New CEO.

Magstim Group, Inc., the pioneer in trans-cranial magnetic stimulation and intraoperative nerve monitoring, today announced that it has appointed Lothar Krinke, Ph.D., as Chief Executive Officer effective immediately. Dr. Krinke will serve on the Board of Directors of Magstim. He will be responsible for Magstim and Technomed.

By |2020-11-05T19:30:15+00:00June 15th, 2017|Company News|0 Comments